Cargando…

Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups

Medulloblastoma comprises four main subgroups (WNT, SHH, Group 3 and Group 4) originally defined by transcriptional profiling. In primary medulloblastoma tissues, these groups are thought to be distinguishable using the immunohistochemical detection of β-catenin, filamin A, GAB1 and YAP1 protein mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chlapek, Petr, Zitterbart, Karel, Kren, Leos, Filipova, Lenka, Sterba, Jaroslav, Veselska, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322931/ https://www.ncbi.nlm.nih.gov/pubmed/28231263 http://dx.doi.org/10.1371/journal.pone.0172552

Ejemplares similares

The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression
por: Chlapek, Petr, et al.
Publicado: (2014)

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
por: Veselska, Renata, et al.
Publicado: (2008)

Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling study
por: Chlapek, Petr, et al.
Publicado: (2010)

The power of natural phenolic compounds: caffeic acid is able to enhance the retinoid-induced differentiation of tumor cells
por: Veselska, Renata, et al.
Publicado: (2014)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids
por: Chlapek, Petr, et al.
Publicado: (2018)

Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
por: Dobrotkova, Viera, et al.
Publicado: (2018)

DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines
por: NERADIL, JAKUB, et al.
Publicado: (2015)

Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers
por: Dobrotkova, Viera, et al.
Publicado: (2019)

Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
por: Veselska, Renata, et al.
Publicado: (2019)

Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology
por: Neradil, Jakub, et al.
Publicado: (2019)

Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms
por: Paukovcekova, Silvia, et al.
Publicado: (2020)

Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
por: Sramek, Martin, et al.
Publicado: (2016)

The Expression of c-Myb Correlates with the Levels of Rhabdomyosarcoma-specific Marker Myogenin
por: Kaspar, Petr, et al.
Publicado: (2015)

Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines
por: Paukovcekova, Silvia, et al.
Publicado: (2020)

Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
por: Paukovcekova, Silvia, et al.
Publicado: (2022)

Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
por: Krchniakova, Maria, et al.
Publicado: (2020)

Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines
por: NUNUKOVA, ALENA, et al.
Publicado: (2015)

Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells
por: Krchniakova, Maria, et al.
Publicado: (2022)

Molecular subgroups of medulloblastoma: the current consensus
por: Taylor, Michael D., et al.
Publicado: (2011)

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
por: Remke, Marc, et al.
Publicado: (2013)

Novel mutations target distinct subgroups of medulloblastoma
por: Robinson, Giles, et al.
Publicado: (2012)

Current medulloblastoma subgroup specific clinical trials
por: Thompson, Eric M., et al.
Publicado: (2020)

Subgroup-specific roles of primary cilia in medulloblastoma
por: Marino, Silvia
Publicado: (2022)

Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis
por: Thompson, Eric M, et al.
Publicado: (2016)

Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup
por: dos Santos Klinger, Paulo Henrique, et al.
Publicado: (2020)

PD-L1 expression in medulloblastoma: an evaluation by subgroup
por: Martin, Allison M., et al.
Publicado: (2018)

Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies
por: Fang, Huangyi, et al.
Publicado: (2022)

Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
por: Park, Ae Kyung, et al.
Publicado: (2019)

OMIC-01. THE LANDSCAPE OF EXTRACHROMOSOMAL CIRCULAR DNA IN MEDULLOBLASTOMA SUBGROUPS
por: Chapman, Owen, et al.
Publicado: (2021)

Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
por: Bevacqua, Emilia, et al.
Publicado: (2021)

MEDB-44. Transcriptomic resolution of subgroup-specific medulloblastoma architecture
por: Willard, Nicholas, et al.
Publicado: (2022)

MEDB-67. Subgroup specific analysis of cellular metabolism in medulloblastoma
por: Funke, Viktoria, et al.
Publicado: (2022)

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
por: Sramek, Martin, et al.
Publicado: (2018)

G-protein coupled receptor expression patterns delineate medulloblastoma subgroups
por: Whittier, Kelsey L, et al.
Publicado: (2013)

Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets
por: Gershanov, Sivan, et al.
Publicado: (2021)

Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts
por: Leskoske, Kristin L., et al.
Publicado: (2022)

Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression
por: Wynn, Daniel T, et al.
Publicado: (2022)

Prognostic significance of molecular subgroups in survival outcome for children with medulloblastoma in Malaysia
por: Rajagopal, Revathi, et al.
Publicado: (2023)

Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype
por: Casciati, Arianna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0h9kam8ccq7ljjvhmcdgnifv7o